• <tr id="yyy80"></tr>
  • <sup id="yyy80"></sup>
  • <tfoot id="yyy80"><noscript id="yyy80"></noscript></tfoot>
  • 99热精品在线国产_美女午夜性视频免费_国产精品国产高清国产av_av欧美777_自拍偷自拍亚洲精品老妇_亚洲熟女精品中文字幕_www日本黄色视频网_国产精品野战在线观看 ?

    Novel 2,4-Diarylaminopyrimidine Derivatives Containing Pyridine Moiety: Design, Synthesis, Crystal Structure and Biological Evaluation①

    2022-03-08 02:30:44LIUJuWUShungWANGHunDUSiYunLIZhenSHENJiWeiCHENYeDINGShi
    結(jié)構(gòu)化學(xué) 2022年1期

    LIU Ju WU Shung WANG Hun DU Si-Yun LI Zhen SHEN Ji-Wei CHEN Ye② DING Shi②

    a (College of Pharmacy of Liaoning University, Shenyang 110036, China)

    b (API Engineering Technology Research Center of Liaoning Province, Shenyang 110036, China)

    c (Small Molecular Targeted Drug R&D Engineering Research Center of Liaoning Province, Shenyang 110036, China)

    ABSTRACT A series of 2,4-diarylaminopyrimidine derivatives containing pyridine structure were designed and synthesized. The crystal structures of compounds 5d and 5e were obtained from X-ray diffraction. The crystal structure of 5d (C25H20ClFN6O2) belongs to the monoclinic system, space group P21/c with a = 11.0500(10), b =18.3045(17), c = 13.5646(9) ? and β = 122.806(5)°. 5e (C25H19ClF2N6O2) is of monoclinic system, space group P21/c with a = 10.9998(18), b = 18.517(3), c = 13.6355(16) ? and β = 123.315(9)°. The bioassay results showed all of the target compounds exhibited potential antiproliferative activities against MKN-45, HT-29, A549, K562 and GIST882 cell lines. Among them, compounds 5a, 5c and 5e exhibited remarkable inhibitory activities against GIST882, K562 and A549 cell lines with IC50 values of 0.68, 0.38 and 0.60 μM, respectively, which were comparable to that of the positive control foretinib.

    Keywords: pyrimidine, pyridine, synthesis, X-ray diffraction, antitumor activity;

    1 INTRODUCTION

    Cancer is one of the most health problems in the world.Although many classes of drugs were used for the treatment,the needs for safe and effective anticancer compounds are still significant target[1,2]. Pyridine and pyrimidine-based compounds have been reported to show remarkable antitumor activities by means of inhibiting multiple enzymes, and some of them are already being marketed or are under clinical/preclinical studies, such as imatinib, sorafenib, crizotinib,abiraterone, BMS-794833, altiratinib, and BMS-777607[3-6].Among above compounds, BMS-794833, altiratinib, and BMS-777607 are representative 4-phenoxypyridine based type II c-Met kinase inhibitors[7,8]. Blocking c-Met kinase activity by small-molecule inhibitors has been identified as a promising approach for the treatment of cancers[9].

    As described in Fig. 1, structurally, most of 4-phenoxypyridine type II c-Met inhibitors may be disconnected into three moieties: a 4-phenoxypyridine core (moiety A), a phenyl or substituted phenyl group (moiety B) and a linker bridge(moiety C). Moiety A and moiety B are crucial for kinase activity[10-12]. With the goal of finding more 4-phenoxypyridine-based antitumor agents,N-[4-(2-fluorophenoxy)pyridin-2-yl]cyclopropanecarboxamide was used as the moiety A.Pyrimidine-2,4-diamine was introduced into the moiety Cviacyclization strategy. Furthermore, various substituents were introduced at the phenyl ring (moiety B) to investigate their effects on activities (Fig. 1). Accordingly, a series of 4-phenoxypyridine derivatives were designed, synthesized and evaluated for theirin vitroantiproliferative activities against MKN-45, HT-29, A549, K562 and GIST882 cancer cell lines.

    2 EXPERIMENTAL

    2. 1 Materials and methods

    Unless otherwise specified, all materials were obtained from commercial suppliers and were used without further purification.1H NMR spectra were recorded on a Bruker Biospin 600 MHz instrument using TMS as the internal standard. All chemical shifts were reported in ppm. IR spectra were recorded as KBr pellets on a Perkin-Elmer Spectrum one FT-IR spectrometer. MS spectra were obtained on an Agilent 6460 QQQ mass spectrometer (Agilent, USA) analysis system.Crystal data were obtained on a Bruker P4 X-diffractometer.

    2. 2 Synthesis of N-(4-chloropyridin2-yl)-cyclopropylformamide (1)

    Cyclopropanecarbonyl chloride (9.30 g, 89.00 mmol) was dissolved in dried CH2Cl2(30 mL) and dropwise added to a mixture of 4-chloropyridin-2-amine (8.80 g, 68.45 mmol),Et3N (20.78 g, 205.35 mmol) and CH2Cl2(80 mL) in an ice bath, which was then removed to raise the temperature to room temperature and stirred for 12 h. The resulting mixture was sequentially washed with 20% K2CO3(50 mL × 3) and brine (50 mL × 3), and the organic phase was separated, dried over anhydrous Na2SO4, filtered, and the filtrate was evaporated under reduced pressure. The crude product obtained was purified by silica gel chromatography to give 9.78 g (yield: 73%) of 1 as a white solid. IR (KBr) cm-1:3242(-NH-), 1707(C=O), 1670, 1588(C=N), 1574(Ar),1537(Ar), 1404, 1257, 1213, 1190, 1150, 960, 873, 824, 710;1H NMR (600 MHz, CDCl3)δ8.79 (s, 1H), 8.31 (s, 1H), 8.16(d,J= 5.4 Hz, 1H), 7.03 (dd,J= 5.4, 1.6 Hz, 1H), 1.60~1.49(m, 1H), 1.17~1.09 (m, 2H), 0.97~0.87 (m, 2H); MS (ESI)m/z (%): 197.1 [M+H]+.

    2. 3 Synthesis of N-(4-(2-fluoro-4-nitrophenoxy)pyridin-2-yl)cyclopropylformamide (2)

    A stirring mixture of compound 8 (8.00 g, 40.68 mmol) and 2-fluoro-4-nitrophenol (15.98 g, 101.71 mmol) in chlorobenzene (100 mL) was refluxed for about 40 h. After cooling to room temperature, the reaction mixture was concentrated under reduced pressure to yield a pale solid. The solid was dissolved in CH2Cl2(150 mL), washed with saturated K2CO3aqueous solution (80 mL × 4) and then brine (60 mL × 4),dried over anhydrous Na2SO4, and finally concentrated under reduced pressure to afford a brown solid, which was purified by silica gel chromatography to give 7.13 g (yield: 55%) of 2 as a light yellow solid. IR (KBr) cm-1: 3418(-NH-),1687(C=O), 1617(C=N), 1529(Ar), 1493(Ar), 1354, 1300,1272, 1180, 1070, 875, 798;1H NMR (600 MHz, DMSO-d6)δ11.00 (s, 1H), 8.43 (dd,J= 10.3, 2.2 Hz, 1H), 8.30 (d,J=5.7 Hz, 1H), 8.19 (dd,J= 9.0, 1.9 Hz, 1H), 7.76 (d,J= 2.2 Hz,1H), 7.61 (t,J= 8.5 Hz, 1H), 6.86 (dd,J= 5.6, 2.2 Hz, 1H),2.04~1.95 (m, 1H), 0.78 (t,J= 6.3 Hz, 4H); MS (ESI) m/z(%): 318.1 [M+H]+.

    2. 4 Synthesis of N-(4-(4-amino-2-fluorophenoxy)pyridin-2-yl)cyclopropanecarboxamide (3)

    A mixture of compound 2 (6.00 g, 18.91 mmol), iron powder (5.28 g, 94.56 mmol), acetic acid (11.36 g, 189.10 mmol), water (20 mL) and ethyl acetate (100 mL) was heated to reflux for 2 h. After completion of the reaction as indicated by TLC, the mixture was filtered immediately. The organic layer of the filtrate was separated, washed with water, dried over anhydrous Na2SO4and filtered, and the filtrate was evaporated under reduced pressure when white solid appeared,which was filtered to obtain 3.51 g (yield: 65%) of 3 as a white solid. IR (KBr) cm-1: 3411(-NH-), 2026, 1737(C=O),1618(C=N), 1510(Ar), 1427, 1207, 1163, 993, 956, 866, 822,610;1H NMR (600 MHz, DMSO-d6)δ10.79 (s, 1H), 8.15 (d,J= 5.7 Hz, 1H), 7.59 (s, 1H), 6.95 (t,J= 9.0 Hz, 1H),6.67~6.61 (m, 1H), 6.49 (dd,J= 13.1, 2.2 Hz, 1H), 6.40 (d,J= 8.7 Hz, 1H), 5.44 (s, 2H), 2.03~1.88 (m, 1H), 0.76 (br, 4H);MS (ESI) m/z (%): 288.1 [M+H]+, 310.1 [M+Na]+.

    2. 5 Synthesis of N-(4-(4-((2-chloropyrimidin-4-yl)amino)-2-fluorophenoxy)pyridin-2-yl)cyclopropane formamide (4)

    A mixture of compound 3 (3.00 g, 10.44 mmol), 2,4-dichloropyrimidine (1.87 g, 12.53 mmol), and diisopropylethylamine (1.35 g, 10.44 mmol) in isopropanol (50 mL) was heated at reflux for 25 h. Upon cooling to room temperature,the mixture evaporated under reduced pressure. The residue was dissolved in dichloromethane (80 mL), and washed with water (50 mL × 3). The organic layer was dried over anhydrous Na2SO4and concentrated under reduced pressure to afford crude product, which was purified by silica gel chromatography to give 3.17 g (yield: 76%) of 4 as a white solid.1H NMR (600 MHz, DMSO-d6)δ10.90 (s, 1H), 10.34(s, 1H), 8.25~8.22 (m, 2H), 7.88~7.60 (m, 2H), 7.50~7.30 (m,2H), 6.85~6.71 (m, 2H), 2.03~1.92 (m, 1H), 0.84~0.72 (m,4H); MS (ESI) m/z (%): 400.1 [M+H]+, 422.0 [M+Na]+.

    2. 6 General procedure for preparing the target compounds (5a~5f)

    A mixture of compound 4 (0.20 g, 0.50 mmol), aromatic amine (1.3 equivalents) andp-toluenesulfonic acid (1.0 equivalent) in isopropanol (8.0 mL) was refluxed for about 18 h. After cooling to room temperature, the resultant precipitate was filtered and dried under vacuum to afford the target compounds 5a~5f as white solid.

    N-(4-(2-fluoro-4-((2-(phenylamino)pyrimidin-4-yl)amino)phenoxy)pyridin-2-yl)cyclopropanecarboxamide (5a)

    Yield: 67%;1H NMR (600 MHz, DMSO-d6)δ10.58 (d,J= 13.1 Hz, 1H), 9.37 (d,J= 11.5 Hz, 1H), 9.05~8.80 (m, 1H),8.20~8.06 (m, 2H), 8.02 (d,J= 5.7 Hz, 1H), 7.81~7.62 (m,3H), 7.37 (d,J= 8.4 Hz, 1H), 7.30~7.19 (m, 2H), 7.10 (t,J=8.8 Hz, 1H), 6.91 (t,J= 7.2 Hz, 1H), 6.65~6.50 (m, 1H), 6.22(d,J= 5.7 Hz, 1H), 2.04~1.89 (m, 1H), 0.91~0.83 (m, 2H),0.79~0.72 (m, 2H); MS (ESI) m/z(%): 457.2 [M+H]+, 479.1[M+Na]+.

    N-(4-(2-fluoro-4-((2-((4-fluorophenyl)amino)pyrimidin-4-yl)amino)phenoxy)pyridin-2-yl)cyclopropanecarboxamide (5b)

    Yield: 59%;1H NMR (600 MHz, DMSO-d6)δ10.74~10.55(m, 1H), 9.53~9.32 (m, 1H), 9.16~8.87 (m, 1H), 8.20~7.92 (m,3H), 7.70 (d,J= 13.4 Hz, 3H), 7.41~7.28 (m, 1H), 7.19~7.04(m, 1H), 7.04~6.88 (m, 2H), 6.64~6.50 (m, 1H), 6.31~6.12 (m,1H), 5.86~5.82 (m, 1H), 2.03~1.88 (m, 1H), 0.96~0.58 (m,4H); IR (KBr, cm-1): 3258(-NH-), 2355, 1678(C=O), 1591,1508(Ar), 1422(Ar), 1312, 1207, 982, 820; MS (ESI) m/z (%):475.2 [M+H]+, 497.1 [M+Na]+.

    N-(4-(4-((2-((4-chlorophenyl)amino)pyrimidin-4-yl)amino)-2-fluorophenoxy)pyridin-2-yl)cyclopropanecarboxamide (5c)

    Yield: 55%;1H NMR (600 MHz, DMSO-d6)δ10.67~10.45(m, 1H), 9.50~9.31 (m, 1H), 9.18~8.92 (m, 1H), 8.26~7.96 (m,3H), 7.79~7.67 (m, 3H), 7.35 (d,J= 7.3 Hz, 1H), 7.26~7.00(m, 3H), 6.59 (dd,J= 5.7, 2.3 Hz, 1H), 6.24 (d,J= 5.7 Hz,1H), 2.07~1.86 (m, 1H), 0.90~0.83 (m, 2H), 0.79~0.73 (m,2H); IR (KBr, cm-1): 3281(-NH-), 2353, 1672(C=O), 1585,1416(Ar), 1308, 1204, 1094, 978, 804, 687; MS (ESI) m/z(%): 491.1 [M+H]+, 513.1 [M+Na]+.

    N-(4-(4-((2-((3-chlorophenyl)amino)pyrimidin-4-yl)amino)-2-fluorophenoxy)pyridin-2-yl)cyclopropanecarboxamide (5d)

    Yield: 57%;1H NMR (600 MHz, DMSO-d6)δ10.51 (br,1H), 9.36 (br, 1H), 9.17~9.04 (m, 1H), 8.13 (d,J= 5.7 Hz,1H), 8.04 (d,J= 5.7 Hz, 1H), 7.95 (s, 1H), 7.92~7.83 (m, 1H),7.74 (d,J= 1.9 Hz, 1H), 7.57 (d,J= 8.2 Hz, 1H), 7.41 (d,J=8.8 Hz, 1H), 7.18 (t,J= 8.1 Hz, 1H), 7.12 (t,J= 8.8 Hz, 1H),6.87 (d,J= 7.9 Hz, 1H), 6.60~6.55 (m, 1H), 6.31~6.22 (m,1H), 2.03~1.84 (m, 1H), 0.91~0.86 (m, 2H), 0.79~0.74 (m,2H); IR (KBr, cm-1): 3305(-NH-), 2357, 1679(C=O), 1619,1416, 1314, 1207, 1105, 990, 808; MS (ESI) m/z (%): 491.1[M+H]+, 513.1 [M+Na]+.

    N-(4-(4-((2-((3-chloro-4-fluorophenyl)amino)pyrimidin-4-yl)amino)-2-fluorophenoxy)pyridin-

    2-yl)cyclopropanecarboxamide (5e)

    Yield: 45%;1H NMR (600 MHz, DMSO-d6)δ10.76~10.50(m, 1H), 9.48 (d,J= 13.0 Hz, 1H), 9.25 (d,J= 13.9 Hz, 1H),8.17~8.10 (m, 1H), 8.06~7.97 (m, 3H), 7.71 (d,J= 3.4 Hz,1H), 7.58 (br, 1H), 7.45~7.33 (m, 1H), 7.20~7.03 (m, 2H),6.64~6.54 (m, 1H), 6.26 (t,J= 6.8 Hz, 1H), 1.97 (d,J= 4.1 Hz, 1H), 0.92~0.71 (m, 4H); IR (KBr, cm-1): 3269(-NH-),2349, 1678(C=O), 1591, 1413(Ar), 1310, 1259, 1207, 1101,990, 808; MS (ESI) m/z (%): 509.1 [M+H]+, 531.1 [M+Na]+.

    N-(4-(2-fluoro-4-((2-(p-tolylamino)pyrimidin-4-yl)amino)phenoxy)pyridin-2-yl)cyclopropanecarboxamide (5f)

    Yield: 62%;1H NMR (600 MHz, DMSO-d6)δ10.63 (s,1H), 9.38 (s, 1H), 8.85 (s, 1H), 8.16~8.08 (m, 2H), 8.00 (d,J= 0.6 Hz, 1H), 7.72 (s, 1H), 7.57 (d,J= 8.3 Hz, 2H), 7.37 (d,J= 8.7 Hz, 1H), 7.10 (t,J= 8.9 Hz, 1H), 7.07~7.01 (m, 2H),6.59 (dd,J= 5.7, 2.3 Hz, 1H), 6.19 (d,J= 5.7 Hz, 1H), 2.27(s, 3H), 2.05~1.90 (m, 1H), 0.89~0.82 (m, 2H), 0.79~0.72 (m,2H); IR (KBr, cm-1): 3196(-NH-), 3017, 2363, 1680(C=O),1586, 1524(Ar), 1420, 1308, 1206, 1101, 986, 804, 700; MS(ESI) m/z (%): 471.2 [M+H]+, 493.2 [M+Na]+.

    2. 7 X-ray data collection and structure refinement

    The white powder of compounds 5d and 5e was dissolved in ethanol/ethyl acetate/tetrahydrofuran = 5:2:3 (V/V/V) and 5:3:1 (V/V/V) mixed solvents, respectively. After slowly evaporating the solvents for several days, some single crystals suitable for X-ray analysis were obtained. The X-ray crystallography data for two crystals were collected on a Bruker APEX-II CCD automatic diffractometer with graphite-monochromatized MoKaradiation (λ= 0.71073 ?)using theφandω-scan mode at 296(2) K. The structure was solved by direct methods and refined with the SHELX crystallographic software package[13]and expanded by Fourier technique. The non-hydrogen atoms were refined anisotropically. The hydrogen atoms bound to carbon were determined with theoretical calculations and those attached to nitrogen and oxygen were determined with successive difference Fourier syntheses. Empirical absorption correction was applied. The structure was solved by direct methods using SADABS[14]. The hydrogen atoms were placed at the calculated positions and refined as riding atoms with isotropic displacement parameters[15]. Crystallographic data and experimental details of structural analyses for 5d and 5e are summarized in Table 1. The hydrogen bonds of the title compound are listed in Table 2, and geometric parameters for it can be found in Table 3.

    Table 1. Crystal Data of Compounds 5d and 5e

    Table 2. Hydrogen Bond Lengths (?) and Bond Angles ( ) of 5d and 5e

    Table 3. Geometric Parameters of 5d and 5e

    C(11)–C(12) 1.388(5) 1.396(4) N(5)–C(19)–N(6) 114.7(3) 114.5(2)C(11)–N(4) 1.401(4) 1.405(3) C(22)–C(23)–C(24) 117.5(3) 115.9(3)C(14)–O(1) 1.382(4) 1.398(3) C(24)–C(23)–C(25) 58.5(3) 58.6(2)C(17)–C(18) 1.377(4) 1.377(4) C(7)–N(1)–C(1) 127.6(3) 127.6(2)C(17)–O(1) 1.379(4) 1.379(3) C(7)–N(2)–C(10) 116.0(3) 115.9(2)C(19)–N(5) 1.333(4) 1.338(3) C(7)–N(3)–C(8) 113.8(3) 113.9(2)C(19)–N(6) 1.399(4) 1.398(3) C(22)–N(6)–C(19) 126.2(3) 126.2(2)C(22)–O(2) 1.226(4) 1.230(3) C(17)–O(1)–C(14) 117.7(2) 116.8(2)C(22)–N(6) 1.362(4) 1.358(3) N(1)–C(1)–C(2)–C(3) –177.3(3) 175.3(2)C(22)–C(23) 1.471(5) 1.464(4) O(1)–C(14)–C(15)–C(16) 178.5(3) 178.3(2 C(23)–C(24) 1.507(5) 1.509(4) N(2)–C(7)–N(1)–C(1) –7.6(5) 6.1(4)C(24)–C(25) 1.477(6) 1.469(4) N(6)–C(22)–C(23)–C(25) –133.3(3) –163.5(2)

    2. 8 In vitro anticancer activity test of the target compounds

    The antiproliferative activities of compounds 5a~5f were evaluated against human gastric cancer cell lines MKN-45,human colon cancer cell lines HT-29, human lung adenocarcinoma cell lines A549, human chronic myeloid leukemia cell lines K562 and human gastrointestinal stromal tumor cell lines GIST882 using the standard MTT assayin vitro, with Foretinib as the positive control. The cancer cell lines were cultured in minimum essential medium (MEM)supplement with 10% fetal bovine serum (FBS). Approximate 4 × 103cells, suspended in MEM medium, were plated onto each well of a 96-well plate and incubated in 5% CO2at 37 C for 24 h. The tested compounds at the indicated final concentrations were added to the culture medium and the cell cultures were continued for 72 h. Fresh MTT was added to each well at a terminal concentration of 5 μg/mL, and incubated with cells at 37 C for 4 h. The formazan crystals were dissolved in 100 mL DMSO each well, and the absorbency at 492 nm (for absorbance of MTT formazan) and 630 nm (for the reference wavelength) was measured with an ELISA reader. All compounds were tested three times in each cell line. The results expressed as IC50(inhibitory concentration 50%) were the averages of three determinations and calculated by using the Bacus Laboratories Incorporated Slide Scanner (Bliss) software.

    3 RESULTS AND DISCUSSION

    3. 1 Synthesis

    The syntheses of target compounds 5a~5f were outlined in Scheme 1. Commercially available 4-chloropyridin-2-amine was condensed with cyclopropanecarbonyl chloride in the presence of Et3N to provide 1, which underwent a nucleophilic substitution with 2-fluoro-4-nitrophenol to give the desired intermediate 2. Reduction of the nitro group of 2 with iron powder and acetic acid in ethyl acetate/water (10:1 v/v)provided aniline compound 3. 3 reacted with 2,4-dichloropyrimidine in refluxingi-PrOH to provide key intermediate 4 under the catalysis of DIPEA. 4 reacted with different substituted anilines in the presence ofp-toluenesulfonic acid in refluxingi-PrOH to yield the target compounds 5a-5f, and the their structures were confirmed by1H NMR, IR and ESI-MS.

    Scheme 1. Synthetic route and structure of target compounds

    3. 2 Crystal structures

    The structures of compounds 5d and 5e were further confirmed by single-crystal X-ray diffraction analysis. The molecular structures of compounds 5d and 5e with atom-numbering are shown in Fig. 2. Both crystal structures of 5d and 5e crystallize in monoclinic space groupP21/c.Their crystal structures show that the two molecules have a 2,4-diarylaminopyrimidine skeleton, in which all bond lengths and bond angles fall in normal ranges. Both of the crystal structures consist of five rings: a three-membered cyclopropane (A), a pyrimidine ring (B), a pyridine ring (C) and two benzene rings (D, E). For compound 5d, the molecule is not coplanar because the dihedral angles between rings A, B and C are 75.44° (A/C), 78.30° (A/B), 61.80° (A/D) and 33.91°(A/E), indicating rings B and C are almost perpendicular to ring A. For compound 5e, the molecule is also not coplanar because the dihedral angles between rings A, B, C, D and E are 75.12° (A/C), 77.42° (A/B), 61.87° (A/D) and 47.67°(A/D), so similar perpendicular conformation is also found.For compounds 5d and 5e, the bond lengths of C(22)–O(2)are 1.226(4) and 1.230(3) ? belonging to the typical C=O double bond[16]. Meanwhile, hydrogen bonding interactions play a significant role in the crystal packing of 5d and 5e(Table 2). A mass of intermolecular hydrogen bonds N(4)–H(4A) O(2), N(3)–H(6A) N(6) and N(6)–H(6) N(3)found in the two compounds play a major role in stabilizing the molecule. And the molecular structures of compounds 5d and 5e are shown in Fig. 3, depicting the molecular packing and hydrogen bonds in a unit cell. Within the molecule, the bond lengths and bond angles present no unusual features.

    Fig. 1. The representative 4-phenoxypyridine type II c-Met kinase inhibitors and design strategy of the target compounds

    Fig. 2. Molecular structure of compound 5d and 5e in a single crystal at 296 K

    3. 3 Biological activity analysis

    Fig. 3. Crystal packing diagrams of compounds 5d and 5e

    The IC50values of 5a~5f and Foretinib against MKN-45,HT-29, A549, K562 and GIST882 cancer cells are presented in Table 4, in which all the tested compounds show excellent antiproliferative activities against different cancer cells with IC50values ranging from 0.38 to 6.29 μM, indicating that newly synthesized 4-phenoxypyridine derivatives maintained antitumor activities. Notably, compounds 5a (R1= H), 5c (R1= 4-Cl) and 5e (R1= 3-Cl-4-F) exhibited remarkable antiproliferative activities against GIST882, K562 and A549 cell lines with IC50values of 0.68 μM (foretinib: 0.75 μM), 0.38 μM(foretinib: 0.39 μM) and 0.60 μM (foretinib: 0.94 μM),respectively, which were all better than the positive control foretinib.

    Table 4. Antiproliferative Activities of Target Compounds against Some Cancer Cells in vitro

    3. 4 Physicochemical and ADME parameters

    Furthermore, some physicochemical and ADME properties of the synthesized compounds and positive controls were predicted using the SwissADME (a free web tool to evaluate pharmacokinetics, drug likeness and medicinal chemistry friendliness of small molecules) for their adaptability with Lipinski's rule of five[17-19]. Compounds obeying at least three of the four criteria are considered to adhere to Lipinski Rule.

    As demonstrated in Table 5, the most active compounds show variable permeability based on gastrointestinal absorption (GI), according to the BOILED-Egg predictive model (Brain Or IntestinaL EstimateD permeation method).All predicted compounds showed high gastrointestinal absorption. With respect to oral bioavailability, it is expected 0.55 of probability of oral bioavailability score >10% in the rat for all compounds, the same as the control drug foretinib(0.55). Compound 5a~5f exhibited potentin vitroantitumor activity, low toxicity and reasonable physicochemical properties, because suitable flexible and size in the bioavailability radar map (Fig. 4). All these data suggests that compound 5a~5f could be considered as a candidate for further research.

    Fig. 4. The bioavailability radar enables a first glance at the drug-likeness of target compounds and Foretinib. The pink area represents the optimal range for each properties (lipophilicity: XLOGP3 between –0.7 and +5.0, size: MW between 150 and 500 g/mol, polarity:TPSA between 20 and 130 ?2, solubility: logS not higher than 6, saturation: fraction of carbons in the sp3 hybridization not less than 0.25, and flexibility: no more than 9 rotatable bonds.

    Table 5. Physicochemical Properties and ADME Properties of Target Compounds

    Electronic supplementary information

    Supplementary data associated with this article have been deposited in the ESI.

    一边摸一边抽搐一进一小说| 精品久久久久久久末码| 十八禁网站免费在线| 九九久久精品国产亚洲av麻豆| 精品人妻1区二区| 日韩欧美国产一区二区入口| 婷婷精品国产亚洲av在线| 在线观看av片永久免费下载| 亚洲专区国产一区二区| 一本综合久久免费| 成年版毛片免费区| .国产精品久久| 国产精品98久久久久久宅男小说| 日本黄大片高清| 又粗又爽又猛毛片免费看| 精品国产三级普通话版| 日本 欧美在线| 国产精品伦人一区二区| 国产探花极品一区二区| 少妇人妻一区二区三区视频| 亚洲av成人av| 一级毛片久久久久久久久女| 美女高潮的动态| 麻豆av噜噜一区二区三区| 窝窝影院91人妻| 亚洲中文字幕一区二区三区有码在线看| 亚洲综合色惰| 欧美乱妇无乱码| 十八禁国产超污无遮挡网站| 亚洲一区二区三区色噜噜| 国产精品免费一区二区三区在线| 精品欧美国产一区二区三| 九色国产91popny在线| 欧美最新免费一区二区三区 | 综合色av麻豆| 两人在一起打扑克的视频| 真人做人爱边吃奶动态| 国产男靠女视频免费网站| 露出奶头的视频| bbb黄色大片| 美女被艹到高潮喷水动态| 不卡一级毛片| 丰满乱子伦码专区| 精品久久久久久久人妻蜜臀av| 国产白丝娇喘喷水9色精品| 丁香欧美五月| 亚洲精品影视一区二区三区av| 精品久久久久久成人av| 小说图片视频综合网站| 日本精品一区二区三区蜜桃| 国产美女午夜福利| 国产在线男女| 国产午夜精品久久久久久一区二区三区 | 怎么达到女性高潮| 精品人妻偷拍中文字幕| 美女xxoo啪啪120秒动态图 | 97超视频在线观看视频| 欧美色视频一区免费| 精品一区二区三区av网在线观看| 此物有八面人人有两片| 丰满乱子伦码专区| 亚洲欧美精品综合久久99| 9191精品国产免费久久| 免费看a级黄色片| 99国产综合亚洲精品| 亚洲成a人片在线一区二区| 久久久久久久久中文| 日韩精品青青久久久久久| a级毛片免费高清观看在线播放| 一进一出抽搐动态| 国产伦在线观看视频一区| 亚洲美女黄片视频| 18美女黄网站色大片免费观看| www.熟女人妻精品国产| av在线蜜桃| 九色成人免费人妻av| 国产人妻一区二区三区在| 国产精品野战在线观看| 美女大奶头视频| 91在线精品国自产拍蜜月| 特大巨黑吊av在线直播| 国内精品一区二区在线观看| 色吧在线观看| 非洲黑人性xxxx精品又粗又长| 久久久久久久久中文| av在线观看视频网站免费| 亚洲狠狠婷婷综合久久图片| 中文字幕免费在线视频6| 黄色日韩在线| 88av欧美| 成年免费大片在线观看| 国产精品98久久久久久宅男小说| 国产黄a三级三级三级人| 狂野欧美白嫩少妇大欣赏| 91在线观看av| 久久99热这里只有精品18| 在线观看午夜福利视频| 国产在线男女| 一区福利在线观看| 一边摸一边抽搐一进一小说| 中文字幕高清在线视频| av天堂在线播放| 超碰av人人做人人爽久久| 亚洲第一欧美日韩一区二区三区| 亚洲色图av天堂| 香蕉av资源在线| 午夜福利视频1000在线观看| 18+在线观看网站| 亚洲自拍偷在线| 69av精品久久久久久| 久久久久精品国产欧美久久久| 夜夜看夜夜爽夜夜摸| 九色成人免费人妻av| 在线免费观看不下载黄p国产 | 久久国产乱子伦精品免费另类| 两个人视频免费观看高清| 亚洲不卡免费看| 成人特级黄色片久久久久久久| 日本精品一区二区三区蜜桃| 国产成人aa在线观看| 91九色精品人成在线观看| 久久国产乱子免费精品| 亚洲av免费高清在线观看| 免费人成在线观看视频色| 神马国产精品三级电影在线观看| 嫩草影院入口| 天堂网av新在线| 久久热精品热| 99国产综合亚洲精品| 欧美日韩亚洲国产一区二区在线观看| 国内精品美女久久久久久| a级毛片免费高清观看在线播放| 国产69精品久久久久777片| 欧美日韩瑟瑟在线播放| 亚洲18禁久久av| 亚洲人与动物交配视频| 亚洲av五月六月丁香网| 男女床上黄色一级片免费看| 欧美中文日本在线观看视频| av福利片在线观看| 两人在一起打扑克的视频| 国产精品国产高清国产av| 色综合亚洲欧美另类图片| 给我免费播放毛片高清在线观看| 亚洲av中文字字幕乱码综合| 国产主播在线观看一区二区| 三级毛片av免费| 日本熟妇午夜| 99热只有精品国产| 欧美色欧美亚洲另类二区| 成人国产综合亚洲| 变态另类丝袜制服| 亚洲精品456在线播放app | 亚洲av.av天堂| 久9热在线精品视频| 国产亚洲精品综合一区在线观看| 国产蜜桃级精品一区二区三区| 午夜精品在线福利| 国产探花极品一区二区| 99在线人妻在线中文字幕| 97超级碰碰碰精品色视频在线观看| 亚洲国产精品合色在线| 亚洲内射少妇av| 美女高潮的动态| av天堂中文字幕网| 美女xxoo啪啪120秒动态图 | 俄罗斯特黄特色一大片| 日本一本二区三区精品| 精华霜和精华液先用哪个| 男插女下体视频免费在线播放| 国产av麻豆久久久久久久| 亚洲国产精品999在线| 欧美成人一区二区免费高清观看| 搡老熟女国产l中国老女人| 久久精品夜夜夜夜夜久久蜜豆| 毛片女人毛片| 99国产精品一区二区三区| 久久中文看片网| 国产成人av教育| 成人国产综合亚洲| 久久久精品欧美日韩精品| 国产成人啪精品午夜网站| 身体一侧抽搐| 啪啪无遮挡十八禁网站| 小蜜桃在线观看免费完整版高清| 久久99热这里只有精品18| 亚洲欧美日韩高清专用| 国产探花在线观看一区二区| 99久国产av精品| 高清毛片免费观看视频网站| 亚洲一区高清亚洲精品| 亚洲,欧美,日韩| 自拍偷自拍亚洲精品老妇| 国产精品精品国产色婷婷| 美女cb高潮喷水在线观看| 午夜精品一区二区三区免费看| 在线观看免费视频日本深夜| 日本与韩国留学比较| 天堂√8在线中文| 一本久久中文字幕| 亚洲男人的天堂狠狠| 99久久九九国产精品国产免费| 无遮挡黄片免费观看| 舔av片在线| 狂野欧美白嫩少妇大欣赏| 免费在线观看日本一区| 中文亚洲av片在线观看爽| 久久精品国产自在天天线| 欧美性感艳星| 午夜激情欧美在线| 久久久精品大字幕| 伦理电影大哥的女人| 91av网一区二区| 一区二区三区四区激情视频 | 婷婷精品国产亚洲av在线| 久久天躁狠狠躁夜夜2o2o| 日日摸夜夜添夜夜添小说| avwww免费| 久99久视频精品免费| 99久久九九国产精品国产免费| 精品久久久久久久久av| 在线播放国产精品三级| 搡老岳熟女国产| 亚洲国产色片| 亚洲成人免费电影在线观看| 99国产精品一区二区蜜桃av| 91在线观看av| 亚洲熟妇中文字幕五十中出| 日韩欧美国产在线观看| 亚洲精品日韩av片在线观看| 国产中年淑女户外野战色| 欧美区成人在线视频| 超碰av人人做人人爽久久| 亚洲欧美日韩高清在线视频| 国产免费av片在线观看野外av| 热99re8久久精品国产| 欧美日韩综合久久久久久 | 老鸭窝网址在线观看| 人人妻人人看人人澡| 高清日韩中文字幕在线| 老司机福利观看| 91字幕亚洲| 一边摸一边抽搐一进一小说| 伦理电影大哥的女人| 色综合站精品国产| 夜夜躁狠狠躁天天躁| 日韩中字成人| 桃色一区二区三区在线观看| 国产精品综合久久久久久久免费| 欧美黑人巨大hd| 午夜免费男女啪啪视频观看 | 最新中文字幕久久久久| 久久久国产成人精品二区| 亚洲一区二区三区色噜噜| 免费人成视频x8x8入口观看| 亚洲一区二区三区不卡视频| 久久久久久久午夜电影| 国内精品久久久久精免费| 一区福利在线观看| 特大巨黑吊av在线直播| 无遮挡黄片免费观看| 成人性生交大片免费视频hd| 国产精品亚洲一级av第二区| 99久久无色码亚洲精品果冻| netflix在线观看网站| 美女高潮喷水抽搐中文字幕| 中文字幕人妻熟人妻熟丝袜美| 久久国产乱子免费精品| 欧美黄色淫秽网站| 免费看a级黄色片| 99在线视频只有这里精品首页| 国产精品国产高清国产av| 久久久精品欧美日韩精品| 亚洲欧美日韩高清在线视频| 97超视频在线观看视频| 中文字幕人妻熟人妻熟丝袜美| 成人三级黄色视频| 日本黄色片子视频| 成人毛片a级毛片在线播放| 最近最新免费中文字幕在线| 激情在线观看视频在线高清| 欧美成人性av电影在线观看| 在线播放无遮挡| 久久人人爽人人爽人人片va | 亚洲国产精品999在线| 日韩 亚洲 欧美在线| 亚洲电影在线观看av| 悠悠久久av| 搡老妇女老女人老熟妇| 18+在线观看网站| 亚洲av成人av| 午夜精品一区二区三区免费看| 99久久精品热视频| 亚洲不卡免费看| 少妇人妻一区二区三区视频| 欧美3d第一页| 亚洲 国产 在线| 欧美乱妇无乱码| 三级男女做爰猛烈吃奶摸视频| 国产黄色小视频在线观看| 中文字幕高清在线视频| 丰满乱子伦码专区| 亚洲中文日韩欧美视频| 欧美性猛交黑人性爽| 欧美一级a爱片免费观看看| 九九久久精品国产亚洲av麻豆| 老司机午夜福利在线观看视频| 亚洲精品亚洲一区二区| 欧美乱妇无乱码| 国产黄片美女视频| 亚洲精品影视一区二区三区av| 亚洲va日本ⅴa欧美va伊人久久| 国产精品爽爽va在线观看网站| 中文字幕久久专区| 欧美黄色片欧美黄色片| 久久国产精品人妻蜜桃| 国产精品,欧美在线| 蜜桃久久精品国产亚洲av| 成人三级黄色视频| 极品教师在线视频| 中文字幕人成人乱码亚洲影| 一卡2卡三卡四卡精品乱码亚洲| 国产三级在线视频| 国产精品亚洲av一区麻豆| 97碰自拍视频| 欧美xxxx性猛交bbbb| 不卡一级毛片| 国产淫片久久久久久久久 | 久久亚洲真实| 国语自产精品视频在线第100页| 嫩草影院新地址| 亚洲国产日韩欧美精品在线观看| 美女xxoo啪啪120秒动态图 | 嫁个100分男人电影在线观看| 网址你懂的国产日韩在线| 岛国在线免费视频观看| 欧美激情久久久久久爽电影| 国产精品久久久久久人妻精品电影| 熟妇人妻久久中文字幕3abv| 精品免费久久久久久久清纯| 757午夜福利合集在线观看| 观看美女的网站| 国产伦一二天堂av在线观看| 观看美女的网站| 国产午夜精品论理片| 露出奶头的视频| 精品久久久久久久人妻蜜臀av| 九色成人免费人妻av| 亚洲欧美日韩高清在线视频| 床上黄色一级片| 亚洲三级黄色毛片| 亚洲精品粉嫩美女一区| 亚洲av中文字字幕乱码综合| 亚洲狠狠婷婷综合久久图片| 一本综合久久免费| 日日干狠狠操夜夜爽| 免费看光身美女| 搡老妇女老女人老熟妇| 伦理电影大哥的女人| 亚洲国产精品成人综合色| 日本熟妇午夜| 天天躁日日操中文字幕| 国产视频一区二区在线看| 一区二区三区免费毛片| 国产精品久久久久久久电影| 一本一本综合久久| 国内精品美女久久久久久| 男人和女人高潮做爰伦理| 国产视频一区二区在线看| 最后的刺客免费高清国语| 欧美最新免费一区二区三区 | 欧美绝顶高潮抽搐喷水| 最近中文字幕高清免费大全6 | 亚洲中文字幕日韩| 真人一进一出gif抽搐免费| 人妻夜夜爽99麻豆av| 久9热在线精品视频| 精品一区二区三区视频在线观看免费| 一区二区三区四区激情视频 | 中文字幕久久专区| 搡老岳熟女国产| 老司机午夜十八禁免费视频| 亚洲电影在线观看av| 亚洲黑人精品在线| 看黄色毛片网站| 亚州av有码| www.熟女人妻精品国产| 午夜影院日韩av| 麻豆国产av国片精品| 亚洲中文日韩欧美视频| 婷婷六月久久综合丁香| 国产成人av教育| 九九在线视频观看精品| 90打野战视频偷拍视频| 一卡2卡三卡四卡精品乱码亚洲| 一进一出抽搐gif免费好疼| 欧美成人一区二区免费高清观看| 欧美日韩国产亚洲二区| 九色成人免费人妻av| av黄色大香蕉| 97人妻精品一区二区三区麻豆| 18禁裸乳无遮挡免费网站照片| netflix在线观看网站| 国产精品一及| 老司机福利观看| 亚洲 国产 在线| 高清毛片免费观看视频网站| 国产成+人综合+亚洲专区| 欧美黄色片欧美黄色片| 久久精品国产99精品国产亚洲性色| 身体一侧抽搐| 日本 欧美在线| netflix在线观看网站| 免费电影在线观看免费观看| 最新在线观看一区二区三区| 精品一区二区三区视频在线观看免费| 日日干狠狠操夜夜爽| 色综合婷婷激情| 亚洲av成人av| 欧美国产日韩亚洲一区| 国内少妇人妻偷人精品xxx网站| 一个人观看的视频www高清免费观看| 精品久久久久久久人妻蜜臀av| 99在线人妻在线中文字幕| 老师上课跳d突然被开到最大视频 久久午夜综合久久蜜桃 | 亚洲熟妇中文字幕五十中出| 最近最新中文字幕大全电影3| 日韩中字成人| 亚洲成人久久爱视频| 婷婷亚洲欧美| 国产一区二区激情短视频| av黄色大香蕉| 村上凉子中文字幕在线| 国产美女午夜福利| 亚洲成人久久性| 亚洲最大成人手机在线| 在线天堂最新版资源| 精品免费久久久久久久清纯| 国产欧美日韩精品一区二区| 香蕉av资源在线| 亚洲欧美精品综合久久99| 欧美在线黄色| 桃色一区二区三区在线观看| 成人av一区二区三区在线看| 久久午夜福利片| 久久国产精品人妻蜜桃| eeuss影院久久| 国产成人欧美在线观看| 日韩成人在线观看一区二区三区| 好男人在线观看高清免费视频| 欧美三级亚洲精品| 亚洲aⅴ乱码一区二区在线播放| 亚洲美女搞黄在线观看 | 欧美xxxx性猛交bbbb| 国产精品98久久久久久宅男小说| 亚洲精华国产精华精| 亚洲va日本ⅴa欧美va伊人久久| 亚洲性夜色夜夜综合| 国产欧美日韩精品一区二区| 久久久久久久久久黄片| 精品99又大又爽又粗少妇毛片 | 少妇人妻一区二区三区视频| 美女高潮的动态| 村上凉子中文字幕在线| 熟女人妻精品中文字幕| 日本黄色视频三级网站网址| а√天堂www在线а√下载| 熟妇人妻久久中文字幕3abv| 午夜亚洲福利在线播放| 日日夜夜操网爽| 国产欧美日韩精品亚洲av| 级片在线观看| 久久婷婷人人爽人人干人人爱| 99热这里只有精品一区| 久久人人精品亚洲av| 欧美日韩福利视频一区二区| 国产一区二区三区视频了| 欧美xxxx黑人xx丫x性爽| 赤兔流量卡办理| 18禁在线播放成人免费| 欧美高清成人免费视频www| 久久久久久国产a免费观看| 高潮久久久久久久久久久不卡| 国产91精品成人一区二区三区| 亚洲美女搞黄在线观看 | 老师上课跳d突然被开到最大视频 久久午夜综合久久蜜桃 | 国产高清激情床上av| 99久国产av精品| 亚洲美女黄片视频| 午夜福利成人在线免费观看| 亚洲中文字幕一区二区三区有码在线看| 亚洲精品影视一区二区三区av| 白带黄色成豆腐渣| 色综合站精品国产| 亚洲中文日韩欧美视频| 综合色av麻豆| 中文在线观看免费www的网站| 国产精品久久久久久精品电影| 日本在线视频免费播放| 亚洲成人中文字幕在线播放| 99热6这里只有精品| 在线观看av片永久免费下载| 成年人黄色毛片网站| 在线天堂最新版资源| 中亚洲国语对白在线视频| 一个人看视频在线观看www免费| 90打野战视频偷拍视频| 怎么达到女性高潮| 亚洲av成人av| 十八禁国产超污无遮挡网站| 欧美黑人欧美精品刺激| 日本在线视频免费播放| 一区福利在线观看| 成年女人毛片免费观看观看9| 精品人妻1区二区| 成人av在线播放网站| 三级国产精品欧美在线观看| 国产亚洲精品久久久com| 亚洲成人久久性| 欧美激情在线99| 国产伦在线观看视频一区| 欧美一区二区国产精品久久精品| 最近最新中文字幕大全电影3| 一区福利在线观看| 欧美高清性xxxxhd video| 男女下面进入的视频免费午夜| 91麻豆av在线| 18禁黄网站禁片免费观看直播| bbb黄色大片| 国产三级中文精品| 免费看日本二区| avwww免费| 日本在线视频免费播放| www.色视频.com| 91麻豆av在线| 国产午夜精品久久久久久一区二区三区 | 亚洲av电影不卡..在线观看| 人人妻人人澡欧美一区二区| 两人在一起打扑克的视频| 久久热精品热| 亚洲成人久久爱视频| 欧美+亚洲+日韩+国产| 午夜激情福利司机影院| 老熟妇仑乱视频hdxx| 美女 人体艺术 gogo| 日韩欧美 国产精品| 51国产日韩欧美| av天堂在线播放| 亚洲av电影不卡..在线观看| 色噜噜av男人的天堂激情| 日韩欧美国产在线观看| 美女大奶头视频| 精品久久久久久成人av| www.色视频.com| 观看免费一级毛片| 亚洲av成人av| 日日夜夜操网爽| 亚洲无线在线观看| 亚洲av中文字字幕乱码综合| 一个人免费在线观看的高清视频| 久久久久久久久中文| 我要搜黄色片| 日本熟妇午夜| 毛片一级片免费看久久久久 | 免费观看精品视频网站| 亚洲自偷自拍三级| 美女被艹到高潮喷水动态| 欧美性猛交黑人性爽| 看黄色毛片网站| 国产一区二区激情短视频| 脱女人内裤的视频| 一二三四社区在线视频社区8| a级一级毛片免费在线观看| 一个人免费在线观看的高清视频| 国产伦在线观看视频一区| 精品免费久久久久久久清纯| 精品福利观看| 精品久久久久久久末码| 一区二区三区激情视频| 51国产日韩欧美| 精品人妻视频免费看| x7x7x7水蜜桃| 午夜影院日韩av| 老司机午夜福利在线观看视频| www日本黄色视频网| 色综合欧美亚洲国产小说| 草草在线视频免费看| 欧美高清性xxxxhd video| 久久精品国产清高在天天线| 男女那种视频在线观看| 成人特级av手机在线观看| 久久久久免费精品人妻一区二区| 亚洲aⅴ乱码一区二区在线播放| 成年版毛片免费区| 国产亚洲精品久久久com| 两个人的视频大全免费| xxxwww97欧美| 国产精品久久久久久亚洲av鲁大| 亚洲精品456在线播放app | 99久久精品热视频| 免费人成在线观看视频色| 久久久久久大精品| 一本综合久久免费| 中亚洲国语对白在线视频| 亚洲 欧美 日韩 在线 免费| 国产成人av教育| 午夜免费成人在线视频| 久久草成人影院| 国产精品一及| 国产激情偷乱视频一区二区| 久久久精品欧美日韩精品| 搡老熟女国产l中国老女人| 日本免费a在线| 又紧又爽又黄一区二区| 成年人黄色毛片网站|